Skip to main content

Table 1 Patient characteristics (n = 129)

From: Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer

 

N (%)

Age

 ≥50

93 (72.1)

 <50

36 (27.9)

 Median age (range)

56 (31–84)

PS

 0

83 (64.3)

 1

39 (30.2)

 2

7 (5.4)

Intrinsic subtype

 Luminal

85 (66.2)

 Luminal-HER2

24 (18.6)

 HER2

10 (7.6)

 Triple negative

10 (7.6)

Metastasis site with bone

 Brain

3 (2.3)

 Liver

13 (10.1)

 Lung

9 (7.0)

Zoledronic acid and/or denosumab use

121 (95.3)

Other bisphosphonate use

5 (3.9)

Median BSI (%)

1.08

Inter quartile range (%)

0.50–3.23

SRE

33 (25.6)

 Surgical therapy received

5 (3.9)

 Radiation therapy received

28 (21.7)

  1. PS performance status